✦ LIBER ✦

Immunotherapeutic strategies for cancer treatment: A novel protein transfer approach for cancer vaccine development

✍ Scribed by Rangaiah Shashidharamurthy; Erica N. Bozeman; Jaina Patel; Ramneet Kaur; Jeyandra Meganathan; Periasamy Selvaraj

Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 365 KB
Volume: 32
Category: Article
ISSN: 0198-6325
DOI: 10.1002/med.20237

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Cancer cells have developed numerous ways to escape immune surveillance and gain unlimited proliferative capacity. Currently, several chemotherapeutic agents and radiotherapy, either alone or in combination, are being used to treat malignancies. However, both of these therapies are associated with several limitations and detrimental side effects. Therefore, recent scientific investigations suggest that immunotherapy is among the most promising new approaches in modern cancer therapy. The focus of cancer immunotherapy is to boost both acquired and innate immunity against malignancies by specifically targeting tumor cells, and leaving healthy cells and tissues unharmed. Cellular, cytokine, gene, and monoclonal antibody therapies have progressively become promising immunotherapeutic approaches that are being tested for several cancers in preclinical models as well as in the clinic. In this review, we discuss recent advances in these immunotherapeutic approaches, focusing on new strategies that allow the expression of specific immunostimulatory molecules on the surface of tumor cells to induce robust antitumor immunity.

📜 SIMILAR VOLUMES

A novel strategy for cancer treatment: T

A novel strategy for cancer treatment: Targeting cancer stem cells

✍ Liu, Jia ;Ma, LeiNa ;Wang, YiGang ;Liu, XinYuan ;Qian, QiJun 📂 Article 📅 2008 🏛 Elsevier 🌐 English ⚖ 495 KB

Cancer vaccines: Clinical development ch

Cancer vaccines: Clinical development challenges and proposed regulatory approaches for patient access to promising treatments

✍ Justin Stebbing; Christopher Wood; Michael Atkins; Ronald Bukowski; Stephen Litw 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB

## Abstract The challenges of late‐stage development increasingly are becoming clear as the clinical development of therapeutic cancer vaccines continues to progress. Preclinical and clinical research had indicated that cancer vaccines exert optimal benefit in earlier stage disease or in adjuvant/m

Effect of hyperthermia on TRAIL-induced

Effect of hyperthermia on TRAIL-induced apoptotic death in human colon cancer cells: Development of a novel strategy for regional therapy

✍ Jinsang Yoo; Yong J. Lee 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 449 KB 👁 2 views

## Abstract Approximately 25% of patients with colorectal cancer will develop metastatic disease exclusively or largely confined to the liver, and the vast majority of these cases are not amenable to surgical resection. These unresectable cases of liver metastatic disease can be treated with isolat

High epitope density in a single protein

High epitope density in a single protein molecule significantly enhances antigenicity as well as immunogenicity: a novel strategy for modern vaccine development and a preliminary investigation about B cell discrimination of monomeric proteins

✍ Wanli Liu; Ying-Hua Chen 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 286 KB 👁 1 views

Site-specific analysis of N-glycans on h

Site-specific analysis of N-glycans on haptoglobin in sera of patients with pancreatic cancer: A novel approach for the development of tumor markers

✍ Miyako Nakano; Tsutomu Nakagawa; Toshifumi Ito; Takatoshi Kitada; Taizo Hijioka; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 French ⚖ 654 KB

## Abstract It was found in our previous studies that the concentration of fucosylated haptoglobin had increased in the sera of patients with pancreatic cancer (PC) compared to those of other types of cancer and normal controls. Haptoglobin, an acute phase protein, has four potential __N__‐glycosyl